United States
Germany
Japan
United Kingdom
China
CNY 5,973.00
5周
ERK2 (MAPK1) (C-term) (incl. pos. control) mouse monoclonal antibody, clone 6G11, Biotin
| Applications | ELISA, IP, WB |
| Reactivities | Canine, Human, Mouse, Rat |
Antibodies
CNY 5,973.00
5周
ERK2 (MAPK1) (N-term) (incl. pos. control) mouse monoclonal antibody, clone 6H3, Biotin
| Applications | ELISA, WB |
| Reactivities | Canine, Human, Mouse, Rat |
Anti-MAPK1 (ERK2) mouse monoclonal antibody, clone OTI1C11 (formerly 1C11)
| Applications | IP, WB |
| Reactivities | Human, Mouse, Rat |
ERK2 (MAPK1) (N-term) rabbit polyclonal antibody, Aff - Purified
| Applications | WB |
| Reactivities | Human, Mouse, Rat |
活动过滤器
优化搜索结果
Category
Antibody Hosts
Knockout (KO) Validation
Conjugates
Modifications
Isotypes
Clonalities
Assay Types
Brands
Pathways
- Acute myeloid leukemia (64)
- Adherens junction (64)
- Alzheimer's disease (64)
- Axon guidance (64)
- B cell receptor signaling pathway (64)
- Bladder cancer (64)
- Chemokine signaling pathway (64)
- Chronic myeloid leukemia (64)
- Colorectal cancer (64)
- Dorso-ventral axis formation (64)
- Endometrial cancer (64)
- ErbB signaling pathway (64)
- Fc epsilon RI signaling pathway (64)
- Fc gamma R-mediated phagocytosis (64)
- Focal adhesion (64)
- Gap junction (64)
- Glioma (64)
- GnRH signaling pathway (64)
- Insulin signaling pathway (64)
- Long-term depression (64)
- Long-term potentiation (64)
- MAPK signaling pathway (64)
- Melanogenesis (64)
- Melanoma (64)
- NOD-like receptor signaling pathway (64)
- Natural killer cell mediated cytotoxicity (64)
- Neurotrophin signaling pathway (64)
- Non-small cell lung cancer (64)
- Oocyte meiosis (64)
- Pancreatic cancer (64)
- Pathways in cancer (64)
- Prion diseases (64)
- Progesterone-mediated oocyte maturation (64)
- Prostate cancer (64)
- Regulation of actin cytoskeleton (64)
- Renal cell carcinoma (64)
- T cell receptor signaling pathway (64)
- TGF-beta signaling pathway (64)
- Thyroid cancer (64)
- Toll-like receptor signaling pathway (64)
- Type II diabetes mellitus (64)
- VEGF signaling pathway (64)
- Vascular smooth muscle contraction (64)
- mTOR signaling pathway (64)
